Functional Hypothalamic Amenorrhea (FHA)
This 43-year-old woman most likely has functional hypothalamic amenorrhea, and the first-line management is addressing underlying energy deficit through nutritional rehabilitation, stress reduction, and exercise modification rather than hormonal therapy.
Diagnostic Interpretation
The hormone pattern is pathognomonic for FHA 1:
- Estradiol <30 pg/mL (markedly suppressed, consistent with FHA threshold of <50 pg/mL)
- Progesterone <0.5 ng/mL (anovulatory, well below the <1 ng/mL cutoff for FHA)
- LH 11.9 and FSH 9.3 IU/L (low-normal range with FSH > LH, the characteristic pattern)
- Total testosterone 23 ng/dL and free testosterone 2.9 pg/mL (low-normal, typical for FHA)
- SHBG 82 nmol/L (upper normal range, consistent with hypoestrogenic state)
This pattern definitively excludes:
- Primary ovarian insufficiency (would show FSH >25-40 IU/L with elevated LH)
- PCOS (would show LH/FSH ratio >2-3, testosterone typically >46 ng/dL, and estradiol often >150 pg/mL) 2
- Hyperprolactinemia or thyroid dysfunction (requires direct measurement per guideline)
Required Initial Workup
Per Endocrine Society guidelines, you must obtain 1:
Mandatory endocrine panel:
- TSH and free T4 (to exclude thyroid dysfunction)
- Prolactin (to exclude hyperprolactinemia >100 ng/mL)
- β-hCG (to exclude pregnancy)
Additional screening if clinically indicated:
- Complete blood count, comprehensive metabolic panel
- Morning 17-hydroxyprogesterone if late-onset CAH suspected
- Consider inflammatory markers (ESR/CRP) if chronic illness suspected
First-Line Management Algorithm
The cornerstone of FHA treatment is non-pharmacologic intervention targeting the underlying energy deficit 1:
1. Nutritional Rehabilitation
- Increase caloric intake to achieve positive energy balance
- Target weight gain if BMI <18.5 or if weight loss preceded amenorrhea
- Referral to registered dietitian experienced in FHA
2. Exercise Modification
- Reduce exercise intensity and duration by 25-50%
- Avoid compulsive or excessive exercise patterns
- Focus on weight-bearing activities when appropriate
3. Stress Management
- Cognitive behavioral therapy
- Address psychological stressors
- Consider mental health referral if eating disorder suspected
4. Monitoring Response
- Reassess hormones every 3-6 months
- Goal: estradiol >50 pg/mL and resumption of menses
- Recovery typically takes 6-12 months with lifestyle modification
Critical Pitfalls to Avoid
Do NOT initiate oral contraceptives as first-line therapy. While OCPs may provide bone protection and cycle control, they mask the underlying problem and prevent monitoring of recovery. The Endocrine Society guideline emphasizes that addressing the root cause (energy deficit) is essential for long-term health outcomes including bone density, cardiovascular health, and fertility 1.
Do NOT assume this is early menopause at age 43. The FSH of 9.3 IU/L is too low for ovarian insufficiency, which requires FSH >25 IU/L on two occasions 4+ weeks apart.
When Hormonal Therapy Is Appropriate
Consider transdermal estradiol (NOT oral contraceptives) with cyclic progestin only if:
- Lifestyle modifications fail after 6-12 months
- Severe bone loss (T-score < -2.5 or fragility fracture)
- Patient unable or unwilling to modify energy deficit
- Age >16 years with prolonged amenorrhea (>6 months)
The Elevated SHBG Context
The SHBG of 82 nmol/L (upper normal, reference 18-86 nmol/L) 3 is consistent with the hypoestrogenic state of FHA. This is NOT indicative of hyperandrogenism—in fact, the low free testosterone (2.9 pg/mL vs. normal 1.2-6.4 pg/mL for a 30-year-old) 3 confirms hypogonadism. The elevated SHBG actually reduces bioavailable sex steroids further, supporting the FHA diagnosis 4.